Cumberland Pharmaceuticals Inc.
CPIX
$6.29
-$0.33-4.99%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -203.18% | -102.73% | 67.66% | 76.20% | 78.89% |
| Total Depreciation and Amortization | -6.40% | -28.91% | -34.36% | -21.33% | -21.14% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 125.49% | 122.44% | 121.19% | -110.24% | -145.34% |
| Change in Net Operating Assets | -43.19% | -27.25% | 47.38% | 146.91% | 152.14% |
| Cash from Operations | -91.90% | -73.80% | 905.70% | 562.80% | 1,095.17% |
| Capital Expenditure | 63.55% | 67.17% | -7.37% | 34.72% | 56.64% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -280.11% | -265.63% | -4,058.89% | -508.67% | -573.53% |
| Cash from Investing | -390.74% | -218.23% | -8,242.56% | -580.85% | -1,388.43% |
| Total Debt Issued | -- | -- | -- | -86.48% | -56.00% |
| Total Debt Repaid | 100.00% | 100.00% | 72.12% | 56.42% | 20.83% |
| Issuance of Common Stock | -100.00% | -100.00% | -- | -- | -- |
| Repurchase of Common Stock | 83.89% | 87.63% | 55.73% | 47.03% | 42.64% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -24.52% | -10.27% | 8.56% | 43.91% | 41.79% |
| Cash from Financing | 75.87% | 74.42% | -3,525.85% | -8,537.87% | -2,847.24% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -306.66% | -19.21% | -1,724.15% | -117.43% | -36.90% |